Analysis Finds Clinical Trial Costs are Actually Modest
June 19, 2020
A new analysis published in BMJ Open suggests that clinical trial costs for new drugs are generally modest, according to a STAT report.
The analysis, which looked at 101 drugs approved by the FDA between 2015 and 2017, found the median cost of clinical trials to be roughly $48 million per drug.
To read the full report on STAT, click here. (Paid subscription required)
